EMR stock icon

Emerson Electric
EMR

$98.19
1.78%

Market Cap: $56.2B

 

About: Emerson Electric sells automation equipment and services under two segments: intelligent devices and software control. Within software and control, it also holds a majority interest in AspenTech, an industrial software business, and owns a test and measurement business that was formerly National Instruments. Intelligent devices also holds Emerson's tools business, which boasts several household brands, like Ridgid. Emerson's automation business is most known for its process manufacturing solutions, which consists of measurement and analytical instrumentation, as well as control valves and actuators, among other products and services. Nearly half of the firm's geographic sales come from the Americas.

Employees: 67,000

0
Funds holding %
of 6,686 funds
0
Analysts bullish %
of 9 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

46% more call options, than puts

Call options by funds: $530M | Put options by funds: $362M

0.16% less ownership

Funds ownership: 76.23% [Q1] → 76.07% (-0.16%) [Q2]

1% less funds holding

Funds holding: 1,907 [Q1] → 1,892 (-15) [Q2]

3% less capital invested

Capital invested by funds: $49.3B [Q1] → $47.9B (-$1.41B) [Q2]

3% less repeat investments, than reductions

Existing positions increased: 688 | Existing positions reduced: 709

10% less first-time investments, than exits

New positions opened: 138 | Existing positions closed: 153

22% less funds holding in top 10

Funds holding in top 10: 18 [Q1] → 14 (-4) [Q2]

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$103
5%
upside
Avg. target
$122
24%
upside
High target
$139
42%
upside

9 analyst ratings

positive
56%
neutral
33%
negative
11%
Morgan Stanley
Chris Snyder
58% 1-year accuracy
7 / 12 met price target
7%upside
$105
Underweight
Initiated
6 Sept 2024
JP Morgan
Stephen Tusa
52% 1-year accuracy
13 / 25 met price target
17%upside
$115
Neutral
Downgraded
14 Aug 2024
RBC Capital
Deane Dray
61% 1-year accuracy
37 / 61 met price target
42%upside
$139
Outperform
Maintained
8 Aug 2024
Barclays
Julian Mitchell
69% 1-year accuracy
49 / 71 met price target
5%upside
$103
Equal-Weight
Maintained
8 Aug 2024
Baird
Michael Halloran
27% 1-year accuracy
6 / 22 met price target
19%upside
$117
Neutral
Maintained
8 Aug 2024

Financial journalist opinion

Based on 17 articles about EMR published over the past 30 days